Status:

UNKNOWN

Impacts of Two Rehabilitation Programs on Chronic Peripheral Facial Paresis

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Facial Palsy

Self-rehabilitation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Introduction: Peripheral facial paresis (PFP) is a very common disease of various etiologies affecting average adults with no predominance of sex. In 70% of cases, motor recovery is rapid and complete...

Eligibility Criteria

Inclusion

  • Age \> 17 yo;
  • Ambulatory patient;
  • Motivation to participate to a rehabilitative facial program for six months;
  • Patient consent to shaving (men) and no makeup (women) in order not to hamper evaluations the morning of the 4 visits of the study ;
  • Signed informed consent;
  • Affiliation to asocial security scheme.

Exclusion

  • Peripheral facial paresis of evolving tumoral etiology;
  • Medical history of botulinum toxin injections in facial muscles during the last 6 months preceding inclusion or injections planned during the study;
  • Medical history of facial surgery in the last two years preceding inclusion or planned during the study;
  • Medical history of facial reanimation surgery needing specific rehabilitation (V-VII or XII-VII anastomosis or muscle transfer);
  • Medical history of medical aesthetic facial treatments (hyaluronic acid/ lipofilling/laser/bracing wires) in the preceding two years before inclusion or planned during the study;
  • Recurrent PFP;
  • Implication in other research interventional protocol dealing with aesthetical aspect of the face or with PFP;
  • Intercurrent pathology impeding the realization of the rehabilitation program during the study;
  • Cognitive, mental or psychiatric troubles impeding the realization of the rehabilitation program or the capacity to attend both evaluations and follow-up consultations;
  • Tutorship or guardianship patient.

Key Trial Info

Start Date :

January 4 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2023

Estimated Enrollment :

82 Patients enrolled

Trial Details

Trial ID

NCT04074018

Start Date

January 4 2021

End Date

June 1 2023

Last Update

June 14 2022

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Centre Hospitalier Intercommunal de Créteil

Créteil, Val De Marne, France, 94010

2

Hôpital Henri Mondor

Créteil, Val De Marne, France, 94010

3

Hôpital Saint-Joseph

Paris, France, 75014